Monitoring of immunity against leukemia stem cell in CML patients after cessation of TKI

類似資料

• CXorf48 is a potential therapeutic target for achieving treatment-free remission in CML patients
  著者:: Matsushita, M, 等
  出版事項: (2017)
• Identification of Novel HLA-A*24:02-Restricted Epitope Derived from a Homeobox Protein Expressed in Hematological Malignancies
  著者:: Matsushita, Maiko, 等
  出版事項: (2016)
• Characteristics of a Novel Target Antigen against Myeloma Cells for Immunotherapy
  著者:: Matsushita, Maiko, 等
  出版事項: (2020)
• Growth effect of tki treatment in childhood CML
  著者:: Jeon, Yeon Jin, 等
  出版事項: (2015)
• Is There a Role for Dose Modification of TKI Therapy in CML?
  著者:: Copland, M.
  出版事項: (2019)